[go: up one dir, main page]

GB201116120D0 - Manipulation of immunoglobulin gene diversity and multi antibody therapeutics, especially for infectious diseases - Google Patents

Manipulation of immunoglobulin gene diversity and multi antibody therapeutics, especially for infectious diseases

Info

Publication number
GB201116120D0
GB201116120D0 GB201116120A GB201116120A GB201116120D0 GB 201116120 D0 GB201116120 D0 GB 201116120D0 GB 201116120 A GB201116120 A GB 201116120A GB 201116120 A GB201116120 A GB 201116120A GB 201116120 D0 GB201116120 D0 GB 201116120D0
Authority
GB
United Kingdom
Prior art keywords
manipulation
infectious diseases
immunoglobulin gene
antibody therapeutics
gene diversity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201116120A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Priority to GB201116120A priority Critical patent/GB201116120D0/en
Publication of GB201116120D0 publication Critical patent/GB201116120D0/en
Priority to EP17196235.0A priority patent/EP3311661B1/en
Priority to EP20171931.7A priority patent/EP3741862A1/en
Priority to EP12762377.5A priority patent/EP2758534B1/en
Priority to BR112014006390A priority patent/BR112014006390A2/en
Priority to AU2012311288A priority patent/AU2012311288B2/en
Priority to NZ623745A priority patent/NZ623745B2/en
Priority to BR112014006394A priority patent/BR112014006394A2/en
Priority to EP22168117.4A priority patent/EP4091442A1/en
Priority to NZ623756A priority patent/NZ623756B2/en
Priority to DK17196235.0T priority patent/DK3311661T3/en
Priority to JP2014531303A priority patent/JP2014531452A/en
Priority to CN201280056727.0A priority patent/CN104080916A/en
Priority to CN201280056528.XA priority patent/CN103945689B/en
Priority to ES12772122.3T priority patent/ES2612935T3/en
Priority to PCT/GB2012/052296 priority patent/WO2013041844A2/en
Priority to DK12762378.3T priority patent/DK2757875T3/en
Priority to JP2014531304A priority patent/JP2014533930A/en
Priority to CA2846322A priority patent/CA2846322A1/en
Priority to PCT/GB2012/052298 priority patent/WO2013041846A2/en
Priority to EP12772122.3A priority patent/EP2758535B1/en
Priority to AU2012311286A priority patent/AU2012311286B2/en
Priority to CN201610821299.6A priority patent/CN107056936B/en
Priority to PCT/GB2012/052297 priority patent/WO2013041845A2/en
Priority to CA2846319A priority patent/CA2846319A1/en
Priority to HK14108036.3A priority patent/HK1194757B/en
Priority to EP20188009.3A priority patent/EP3839049A3/en
Priority to EP16189625.3A priority patent/EP3128009B1/en
Priority to JP2014531302A priority patent/JP5813880B2/en
Priority to CN201610883894.2A priority patent/CN106995822B/en
Priority to EP12762378.3A priority patent/EP2757875B2/en
Priority to US14/052,259 priority patent/US20140041067A1/en
Priority to US14/220,099 priority patent/US20140323327A1/en
Priority to US14/220,074 priority patent/US11051497B2/en
Priority to JP2015182782A priority patent/JP6324355B2/en
Priority to JP2017021028A priority patent/JP7067868B2/en
Priority to JP2017177720A priority patent/JP2017213005A/en
Priority to US15/786,281 priority patent/US20180030121A1/en
Priority to AU2017254949A priority patent/AU2017254949A1/en
Priority to US17/368,266 priority patent/US20220000085A1/en
Ceased legal-status Critical Current

Links

GB201116120A 2011-09-19 2011-09-19 Manipulation of immunoglobulin gene diversity and multi antibody therapeutics, especially for infectious diseases Ceased GB201116120D0 (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GB201116120A GB201116120D0 (en) 2011-09-19 2011-09-19 Manipulation of immunoglobulin gene diversity and multi antibody therapeutics, especially for infectious diseases
EP12762378.3A EP2757875B2 (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
CA2846322A CA2846322A1 (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
PCT/GB2012/052298 WO2013041846A2 (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
EP12762377.5A EP2758534B1 (en) 2011-09-19 2012-09-18 Animals, repertoires & methods for the production of human antibodies
BR112014006390A BR112014006390A2 (en) 2011-09-19 2012-09-18 antibodies, variable domains and chains made especially for human use
AU2012311288A AU2012311288B2 (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
NZ623745A NZ623745B2 (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
BR112014006394A BR112014006394A2 (en) 2011-09-19 2012-09-18 manipulation of immunoglobulin genetic diversity and therapeutic multi-antibodies
EP22168117.4A EP4091442A1 (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
NZ623756A NZ623756B2 (en) 2011-09-19 2012-09-18 Antibodies, variable domains & chains tailored for human use
DK17196235.0T DK3311661T3 (en) 2011-09-19 2012-09-18 MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND THERAPEUTIC DRUGS WITH MULTIPLE ANTIBODIES
JP2014531303A JP2014531452A (en) 2011-09-19 2012-09-18 Animals, repertoire and methods
CN201280056727.0A CN104080916A (en) 2011-09-19 2012-09-18 Custom antibodies, variable domains and chains for human use
CN201280056528.XA CN103945689B (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
ES12772122.3T ES2612935T3 (en) 2011-09-19 2012-09-18 Antibodies, variable domains and chains adapted for use in humans
EP20171931.7A EP3741862A1 (en) 2011-09-19 2012-09-18 Animals, repertoires & methods for the production of human antibodies
DK12762378.3T DK2757875T3 (en) 2011-09-19 2012-09-18 MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND MULTI-ANTIBODY THERAPEUTICS
JP2014531304A JP2014533930A (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
EP17196235.0A EP3311661B1 (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
EP12772122.3A EP2758535B1 (en) 2011-09-19 2012-09-18 Antibodies, variable domains&chains tailored for human use
PCT/GB2012/052296 WO2013041844A2 (en) 2011-09-19 2012-09-18 Antibodies, variable domains & chains tailored for human use
EP20188009.3A EP3839049A3 (en) 2011-09-19 2012-09-18 Antibodies, variable domains & chains tailored for human use
CN201610821299.6A CN107056936B (en) 2011-09-19 2012-09-18 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
PCT/GB2012/052297 WO2013041845A2 (en) 2011-09-19 2012-09-18 Animals, repertoires & methods
CA2846319A CA2846319A1 (en) 2011-09-19 2012-09-18 Antibodies, variable domains & chains tailored for human use
HK14108036.3A HK1194757B (en) 2011-09-19 2012-09-18 Antibodies, variable domains & chains tailored for human use
AU2012311286A AU2012311286B2 (en) 2011-09-19 2012-09-18 Antibodies, variable domains and chains tailored for human use
EP16189625.3A EP3128009B1 (en) 2011-09-19 2012-09-18 Antibodies, variable domains & chains tailored for human use
JP2014531302A JP5813880B2 (en) 2011-09-19 2012-09-18 Antibodies, variable domains and chains made for human use
CN201610883894.2A CN106995822B (en) 2011-09-19 2012-09-18 Customize antibodies, variable domains and chains for human use
US14/052,259 US20140041067A1 (en) 2011-09-19 2013-10-11 Antibodies, variable domains & chains tailored for human use
US14/220,099 US20140323327A1 (en) 2011-09-19 2014-03-19 Animals, repertoires & methods
US14/220,074 US11051497B2 (en) 2011-09-19 2014-03-19 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
JP2015182782A JP6324355B2 (en) 2011-09-19 2015-09-16 Antibodies, variable domains and chains made for human use
JP2017021028A JP7067868B2 (en) 2011-09-19 2017-02-08 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
JP2017177720A JP2017213005A (en) 2011-09-19 2017-09-15 Animals, repertoire and methods
US15/786,281 US20180030121A1 (en) 2011-09-19 2017-10-17 Antibodies, variable domains & chains tailored for human use
AU2017254949A AU2017254949A1 (en) 2011-09-19 2017-11-03 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US17/368,266 US20220000085A1 (en) 2011-09-19 2021-07-06 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201116120A GB201116120D0 (en) 2011-09-19 2011-09-19 Manipulation of immunoglobulin gene diversity and multi antibody therapeutics, especially for infectious diseases

Publications (1)

Publication Number Publication Date
GB201116120D0 true GB201116120D0 (en) 2011-11-02

Family

ID=44937466

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201116120A Ceased GB201116120D0 (en) 2011-09-19 2011-09-19 Manipulation of immunoglobulin gene diversity and multi antibody therapeutics, especially for infectious diseases

Country Status (1)

Country Link
GB (1) GB201116120D0 (en)

Similar Documents

Publication Publication Date Title
IL251697A0 (en) Anti-erbb3 antibodies and uses thereof
IL259826A (en) Anti-alphabetatcr antibody
TWI561531B (en) Anti b7-h3 antibody
ZA201400768B (en) Interleukin-31 monoclonal antibody
EP2722343A4 (en) ANTI-erbB3 ANTIBODY
EP2749572A4 (en) Novel anti-ddr1 antibody having anti-tumor activity
GB201115529D0 (en) Antibodies, uses and methods
GB201115280D0 (en) Antibodies, uses and methods
PT2768857T (en) Methods of purifying antibodies
ZA201400062B (en) Tnf-alpha antigen-binding proteins with increased fcrn binding
GB201103955D0 (en) Antibodies
GB201112056D0 (en) Antibodies
ZA201400561B (en) Axmi279 pesticidal gene and methods for its use
ZA201208541B (en) Antibody preparations
EP2746394A4 (en) Antibody and antibody-containing composition
IL231404A0 (en) Antibody against affinity complex
EP2707392A4 (en) Monoclonal antibody for acetylamantadine
IL228101A0 (en) Antibodies that bind tgf-alpha and epiregulin
EP2700710A4 (en) Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof
GB201116120D0 (en) Manipulation of immunoglobulin gene diversity and multi antibody therapeutics, especially for infectious diseases
EP2669297A4 (en) Humanized anti-egfr antibody l4-h3 and coding gene thereof
HK1197751A (en) Antigen-binding proteins with increased fcrn binding
GB201117681D0 (en) Matrix binders, uses thereof and methods of manufacture
GB201208749D0 (en) Synthetically-extended & ethnically-diverse superhuman immunoglobulin gene repertoires

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)